rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    DYAI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Dyadic: 3 Key Takeaways for Long-Term Investors
      Nov 13Yahoo FinanceDYAI
      Dyadic International Inc (DYAI) (Q3 2026) Earnings Call Highlights: Transferrin Breakthrough, ...

      Dyadic International Inc (DYAI) posted an 80% productivity gain in its animal-free transferrin program and began product shipments, but flat revenue and liquidity concerns cloud the outlook.

      Nov 13Yahoo FinanceDYAI
      Earnings call transcript: Dyadic International posts Q3 2026 revenue miss
      Nov 12Investing.comDYAI
      Dyadic earnings missed by $0.01, revenue fell short of estimates
      Nov 12Investing.comDYAI
      12 Health Care Stocks Moving In Tuesday's Pre-Market Session
      Nov 3BenzingaAEMDDYAI
      Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026
      Oct 30Yahoo FinanceDYAI
      Dyadic at Lytham Partners: push from platform to sales
      Sep 29Investing.comDYAI
      Dyadic International (DYAI) Stock Analysis Report | Ratings, Financials & Performance
      Sep 27BenzingaDYAI
      Dyadic International Faces Nasdaq Listing Compliance Challenges

      Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.

      Sep 26The Globe and MailDYAI
      Dyadic International (Nasdaq: DYAI) Advances Protein Manufacturing Platforms with Global Health Research Support

      Support from global health organizations highlights continued development of Dyadic’s C1 and Dapibus platforms for

      Sep 1USA TodayDYAI
      Imperium AI Announces Board Discussion Regarding Dyadic Biotechnology Developments

      Imperium AI Founder and CEO Shazir Mucklai will lead an internal review of Dyadic’s biotechnology platforms,

      Sep 1USA TodayDYAI
      Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products

      Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products

      Aug 31BarchartDYAI
      Imperium AI CEO Shazir Mucklai on Major Potential in Dyadic (NASDAQ: DYAI), Calls Board Meeting to Discuss Next Steps

      Imperium AI CEO Shazir Mucklai on Major Potential in Dyadic (NASDAQ: DYAI), Calls Board Meeting to Discuss Next Steps

      Aug 31BarchartDYAI
      Dyadic Applied BioSolutions at q3 investor summit group virtual conference 2026: push to cash flow By Investing.com
      Aug 26Investing.comDYAI

      This is the newest page. Registered accounts read further back.